Perceptions of Noninvasive Ventilation During Exercise in Noninvasive Ventilation-Naïve Patients With COPD.


Journal

Respiratory care
ISSN: 1943-3654
Titre abrégé: Respir Care
Pays: United States
ID NLM: 7510357

Informations de publication

Date de publication:
05 2022
Historique:
pubmed: 24 3 2022
medline: 29 4 2022
entrez: 23 3 2022
Statut: ppublish

Résumé

The perceptions of using noninvasive ventilation (NIV) during exercise in patients with COPD who are naïve to NIV is unknown. The present study aimed to examine the perceptions of using NIV during exercise in people with COPD and to determine the relationship between patient perceptions with both baseline patient characteristics and exercise outcomes. During a trial examining the effect of NIV during exercise on dynamic hyperinflation in people with COPD who were naïve to NIV, participants completed a 5-point Likert scale questionnaire (scored strongly disagree -2 to strongly agree +2) before and after using NIV during exercise and a semi-structured interview after using NIV during exercise. Eighteen participants, mean age (SD) 69 (7) y, FEV Individuals with COPD, naïve to NIV, and using NIV during exercise for the first time reported a positive effect of NIV on breathlessness and exercise performance. Participants' perceived benefit of NIV correlated moderately with increased endurance time and resting hyperinflation and with a reduction in dynamic hyperinflation during exercise, suggesting that patient reports could also aid selection of those who will benefit from NIV during exercise.

Sections du résumé

BACKGROUND
The perceptions of using noninvasive ventilation (NIV) during exercise in patients with COPD who are naïve to NIV is unknown. The present study aimed to examine the perceptions of using NIV during exercise in people with COPD and to determine the relationship between patient perceptions with both baseline patient characteristics and exercise outcomes.
METHODS
During a trial examining the effect of NIV during exercise on dynamic hyperinflation in people with COPD who were naïve to NIV, participants completed a 5-point Likert scale questionnaire (scored strongly disagree -2 to strongly agree +2) before and after using NIV during exercise and a semi-structured interview after using NIV during exercise.
RESULTS
Eighteen participants, mean age (SD) 69 (7) y, FEV
CONCLUSIONS
Individuals with COPD, naïve to NIV, and using NIV during exercise for the first time reported a positive effect of NIV on breathlessness and exercise performance. Participants' perceived benefit of NIV correlated moderately with increased endurance time and resting hyperinflation and with a reduction in dynamic hyperinflation during exercise, suggesting that patient reports could also aid selection of those who will benefit from NIV during exercise.

Identifiants

pubmed: 35318238
pii: respcare.09657
doi: 10.4187/respcare.09657
doi:

Types de publication

Clinical Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

543-552

Informations de copyright

Copyright © 2022 by Daedalus Enterprises.

Déclaration de conflit d'intérêts

The authors have disclosed no conflicts of interest.

Auteurs

Clancy J Dennis (CJ)

University of Sydney, Faculty of Medicine and Health, Sydney, New South Wales, Australia. cden2754@uni.sydney.edu.au.

Collette Menadue (C)

Department of Respiratory and Sleep Medicine, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.

Tessa Schneeberger (T)

Institute for Pulmonary Rehabilitation Research, Schoen Klinik Berchtesgadener Land, Schoenau am Koenigssee, Germany; and Department of Pulmonary Rehabilitation, Philipps-University of Marburg, German Centre for Lung Research, Marburg, Germany.

Daniela Leitl (D)

Institute for Pulmonary Rehabilitation Research, Schoen Klinik Berchtesgadener Land, Schoenau am Koenigssee, Germany; and Department of Pulmonary Rehabilitation, Philipps-University of Marburg, German Centre for Lung Research, Marburg, Germany.

Ursula Schoenheit-Kenn (U)

Institute for Pulmonary Rehabilitation Research, Schoen Klinik Berchtesgadener Land, Schoenau am Koenigssee, Germany.

Alison R Harmer (AR)

University of Sydney, Faculty of Medicine and Health, Sydney, New South Wales, Australia.

David J Barnes (DJ)

University of Sydney, Faculty of Medicine and Health, Sydney, New South Wales, Australia; and Department of Respiratory and Sleep Medicine, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.

Andreas R Koczulla (AR)

Institute for Pulmonary Rehabilitation Research, Schoen Klinik Berchtesgadener Land, Schoenau am Koenigssee, Germany; Department of Pulmonary Rehabilitation, Philipps-University of Marburg, German Centre for Lung Research, Marburg, Germany; and Teaching Hospital, Paracelsus Medical University, Salzburg, Austria.

Klaus Kenn (K)

Institute for Pulmonary Rehabilitation Research, Schoen Klinik Berchtesgadener Land, Schoenau am Koenigssee, Germany; and Department of Pulmonary Rehabilitation, Philipps-University of Marburg, German Centre for Lung Research, Marburg, Germany.

Jennifer A Alison (JA)

University of Sydney, Faculty of Medicine and Health, Sydney, New South Wales, Australia; and Sydney Local Health District, Allied Health, Sydney, New South Wales, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH